Tris Pharma Inc., a pharmaceutical company based in Monmouth Junction, announced Wednesday it has named Jonathan N. Provoost as general counsel, responsible for all company legal functions.
“With our continued growth and evolution to a larger, more complex operation, one of our priorities have been to bring a seasoned pharmaceutical lawyer in to join Tris’ senior leadership team. We are thrilled that Jonathan has joined Tris as our vice president and general counsel,” Ketan Mehta, founder and CEO, Tris Pharma, said. “Jonathan brings a well-rounded perspective to Tris’ leadership team having worked in critical functional areas such as Intellectual Property, Corporate Compliance, and general transactional business activities.”
Provoost, who has more than 20 years of experience in the legal industry, most recently served as general counsel for business development and licensing at Mallinckrodt Pharmaceuticals. He’s also worked at Ikaria, PTC Therapeutics, Kos Pharmaceuticals, Bristol-Myers Squibb and Exxon Mobile Corp.
“I am honored to have the opportunity to lead Tris’ legal function. Tris’ impressive growth trajectory and product pipeline provide a robust foundation upon which we can build Tris into a leading global specialty pharmaceutical company,” Provoost said. “I look forward to working with my colleagues to advance the continued growth and expansion of Tris’ business.”
